151 related articles for article (PubMed ID: 36952359)
1. Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population-based study from China.
Wang DY; Li SF; Gao SL; Yuan P; Zhang BL
Cancer Med; 2023 Apr; 12(8):9644-9649. PubMed ID: 36952359
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
4. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
5. A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis.
Chen YQ; Xu XF; Xu JW; Di TY; Wang XL; Huo LQ; Wang L; Gu J; Zhou GH
Transl Oncol; 2022 Aug; 22():101467. PubMed ID: 35700595
[TBL] [Abstract][Full Text] [Related]
6. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
7. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.
Hao S; Zhao YY; Peng JJ; Ren F; Yang WT; Yu KD; Shao ZM
Sci Rep; 2019 Jan; 9(1):286. PubMed ID: 30670771
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
Wu Y; Zhang N; Yang Q
BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
[TBL] [Abstract][Full Text] [Related]
9. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Chen Z; Yang J; Li S; Lv M; Shen Y; Wang B; Li P; Yi M; Zhao X; Zhang L; Wang L; Yang J
PLoS One; 2017; 12(9):e0182397. PubMed ID: 28863134
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Characteristics and Prognosis of Invasive Papillary Carcinoma of the Breast.
Huang K; Appiah L; Mishra A; Bagaria SP; Gabriel ME; Misra S
J Surg Res; 2021 May; 261():105-112. PubMed ID: 33422900
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
Cao AY; He M; Huang L; Shao ZM; Di GH
World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
[TBL] [Abstract][Full Text] [Related]
12. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
[TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
[TBL] [Abstract][Full Text] [Related]
14. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
Hua B; Lu X; Xiao WZ; He SR; Wang Z
Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
[No Abstract] [Full Text] [Related]
15. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
[TBL] [Abstract][Full Text] [Related]
16. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Angarita FA; Rodríguez JL; Meek E; Sánchez JO; Tawil M; Torregrosa L
World J Surg Oncol; 2013 Jun; 11():128. PubMed ID: 23734899
[TBL] [Abstract][Full Text] [Related]
17. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.
Yang L; Roy M; Lin H; Shen Y; Albarracin C; Huo L; Chen H; Wei B; Bedrosian I; Bu H; Wu Y
Breast Cancer Res Treat; 2021 Apr; 186(2):403-415. PubMed ID: 33528758
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.
Yang L; Lin H; Shen Y; Roy M; Albarracin C; Ding Q; Huo L; Chen H; Wei B; Bu H; Bedrosian I; Wu Y
Breast Cancer Res Treat; 2023 Nov; 202(1):23-32. PubMed ID: 37566192
[TBL] [Abstract][Full Text] [Related]
19. Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.
Lee WP; Shetty SS; Seah CMJ; Tan PT; Tan SM
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1646. PubMed ID: 35892151
[TBL] [Abstract][Full Text] [Related]
20. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
